• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性后视网膜色素上皮撕裂的空间模式及其进展。

SPATIAL PATTERN OF RETINAL PIGMENT EPITHELIUM TEAR DEVELOPMENT AND PROGRESSION AFTER ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

机构信息

Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Retin Cases Brief Rep. 2024 May 1;18(3):371-377. doi: 10.1097/ICB.0000000000001386.

DOI:10.1097/ICB.0000000000001386
PMID:36730109
Abstract

PURPOSE

The aim of this study was to demonstrate the spatial pattern of retinal pigment epithelium (RPE) tear development and progression after antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.

METHODS

We retrospectively reviewed six eyes with neovascular age-related macular degeneration that showed RPE tears after administration of intravitreal antivascular endothelial growth factor agents and were followed up for 12 months. The patterns of RPE tear development and progression were evaluated by analyzing positional relationships among the locations of the choroidal neovascularization membrane and pigment epithelial detachment (PED) area at baseline and the tear area using spectral-domain optical coherence tomography, color photography, fluorescein angiography, and fundus autofluorescence images.

RESULTS

Pretear OCT images revealed fibrovascular PED in all eyes, one of which showed complications of hemorrhagic PED after treatment. In five eyes, RPE tears developed at the PED edge located on the opposite side of the choroidal neovascularization membrane. In the eye showing hemorrhagic PED, the RPE tear developed along the wide area of the PED edge. The torn RPE monolayer contracted toward the side of the choroidal neovascularization membrane in all eyes, and RPE loss involved the fovea in five eyes that showed significantly worse visual acuity (VA) after 12 months in comparison with the baseline value before the tear (logMAR VA; 0.3 vs. 1.29; P < 0.02).

CONCLUSION

The location of choroidal neovascularization membrane in PED determines the spatial pattern of RPE tear development and progression and helps to predict the visual outcome after RPE tears.

摘要

目的

本研究旨在展示抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性后视网膜色素上皮(RPE)撕裂的空间模式及其进展。

方法

我们回顾性分析了 6 只接受玻璃体内抗血管内皮生长因子药物治疗后出现 RPE 撕裂的新生血管性年龄相关性黄斑变性眼,随访时间为 12 个月。通过分析基线时脉络膜新生血管膜和色素上皮脱离(PED)区的位置与撕裂区之间的位置关系,使用频域光相干断层扫描、彩色照相、荧光素血管造影和眼底自发荧光图像评估 RPE 撕裂的发展和进展模式。

结果

所有眼在预撕裂 OCT 图像中均显示出纤维血管性 PED,其中 1 只在治疗后出现了出血性 PED 并发症。在 5 只眼中,PED 边缘位于脉络膜新生血管膜的对侧出现了 RPE 撕裂。在出现出血性 PED 的眼中,RPE 撕裂沿着PED 边缘的宽区发展。所有眼中撕裂的 RPE 单层均向脉络膜新生血管膜侧收缩,5 只眼在撕裂后 12 个月的最佳矫正视力(VA)明显低于撕裂前的基线值(logMAR VA;0.3 与 1.29;P < 0.02),且累及黄斑中心凹。

结论

PED 中的脉络膜新生血管膜位置决定了 RPE 撕裂的发展和进展的空间模式,并有助于预测 RPE 撕裂后的视力结果。

相似文献

1
SPATIAL PATTERN OF RETINAL PIGMENT EPITHELIUM TEAR DEVELOPMENT AND PROGRESSION AFTER ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性后视网膜色素上皮撕裂的空间模式及其进展。
Retin Cases Brief Rep. 2024 May 1;18(3):371-377. doi: 10.1097/ICB.0000000000001386.
2
The factors associated with retinal pigment epithelium tear development in the early phase after treatment initiation for age-related macular degeneration.与年龄相关性黄斑变性治疗启动后早期视网膜色素上皮撕裂发展相关的因素。
Graefes Arch Clin Exp Ophthalmol. 2024 Oct;262(10):3171-3180. doi: 10.1007/s00417-024-06503-z. Epub 2024 May 7.
3
Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.雷珠单抗每月治疗年龄相关性黄斑变性所致血管性色素上皮脱离的疗效:前瞻性、多中心RECOVER研究
Acta Ophthalmol. 2017 Nov;95(7):683-689. doi: 10.1111/aos.13359. Epub 2017 Jan 13.
4
RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.视网膜色素上皮撕裂与抗血管内皮生长因子疗法治疗渗出性年龄相关性黄斑变性:临床病程与长期预后
Retina. 2016 May;36(5):868-74. doi: 10.1097/IAE.0000000000000823.
5
Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.频域光相干断层扫描揭示玻璃体内抗血管内皮生长因子治疗后视网膜色素上皮撕裂的形成机制。
Am J Ophthalmol. 2013 Nov;156(5):981-988.e2. doi: 10.1016/j.ajo.2013.06.024. Epub 2013 Aug 20.
6
Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.玻璃体腔内注射贝伐单抗治疗新生血管性年龄相关性黄斑变性后视网膜色素上皮撕裂
Retina. 2007 Jun;27(5):541-51. doi: 10.1097/IAE.0b013e3180cc2612.
7
RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.玻璃体腔内注射雷珠单抗治疗新生血管性年龄相关性黄斑变性后视网膜色素上皮撕裂
Retina. 2016 Oct;36(10):1851-9. doi: 10.1097/IAE.0000000000001009.
8
Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性后早期和晚期视网膜色素上皮撕裂。
Ophthalmology. 2018 Feb;125(2):237-244. doi: 10.1016/j.ophtha.2017.08.039. Epub 2017 Oct 6.
9
DOUBLE RETINAL PIGMENT EPITHELIUM TEARS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.新生血管性年龄相关性黄斑变性中的双视网膜色素上皮撕裂
Retina. 2016 Nov;36(11):2197-2204. doi: 10.1097/IAE.0000000000001062.
10
Anatomical and visual outcomes of ranibizumab injections in retinal pigment epithelium tears.玻璃体内注射雷珠单抗治疗视网膜色素上皮撕裂的解剖学和视觉效果
Arq Bras Oftalmol. 2015 May-Jun;78(3):168-72. doi: 10.5935/0004-2749.20150043.

引用本文的文献

1
CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS Study.创新型雷珠单抗与生物类似药雷珠单抗在脉络膜视网膜血管疾病中的比较安全性分析——CRsIBS研究
Clin Ophthalmol. 2025 Mar 28;19:1093-1102. doi: 10.2147/OPTH.S515479. eCollection 2025.